2027 年までの北米結腸直腸がん市場 - モダリティ別の地域分析と予測 (診断タイプ、治療タイプ、画像タイプ)。エンドユーザー (病院、診断研究所、研究所)、および国

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 157    |    Report Code: TIPRE00009241    |    Category: Life Sciences

North America Colorectal Cancer Market

北米の結腸直腸がん市場は、2022年の85億5,927万米ドルから2028年までに111億9,811万米ドルに成長すると予想されています。 2022 年から 2028 年にかけて 3.4% の CAGR で成長すると推定されています。

 

結腸直腸がんは、最も深刻ながんの 1 つです。遺伝的要因と環境的要因の複合的な影響により、個人によく見られる致死的ながん。北米ではかなりの人口が結腸直腸がんと診断されています。疾病管理予防センター (CDC) と米国癌協会によると、2020 年に米国で推定 193 万人の成人が結腸および直腸癌と診断され、53,200 人が結腸直腸癌により死亡しました。これらの統計は需要の増加を示しています。地域における先進的ながんの診断と治療を目指しています。したがって、結腸直腸がんの罹患率の上昇と結腸直腸がんと診断される患者数の増加が、北米の結腸直腸がん市場の成長を推進しています。

 

新しい機能とテクノロジーを使用することで、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因により、予測期間中に北米の結腸直腸がん市場は大幅な CAGR で成長すると考えられます。

 

 

北米結腸直腸がん

市場収益と2028年までの予測(百万米ドル)

 

 

 

北米結腸直腸がん市場セグメンテーション

 

北米結腸直腸がん市場モダリティ、エンドユーザー、および国に分類されます。北米の結腸直腸がん市場は、モダリティに基づいて、診断タイプ、治療タイプ、画像タイプに分類されます。 2022 年には、診断タイプのセグメントが最大の市場シェアを保持し、予測期間中に最高の CAGR を記録すると予想されます。エンドユーザーに基づいて、北米の結腸直腸がん市場は病院と診断および検査に二分されます。研究室。 2022 年には、病院部門がより大きな市場シェアを獲得しました。北米の結腸直腸がん市場は国ごとに米国、カナダ、メキシコに分割されています。 2022 年に米国が最大の市場シェアを獲得しました。

 

Abbott、Amgen Inc.、Bruker Corporation、Clinical Genomics Technologies Pty Ltd.、エピゲノミクスAG、F. Hoffmann-La Roche AG、Quest Diagnostics、VolitionRx Limited は、北米の結腸直腸がん市場で事業を展開する大手企業です。  



North America Colorectal Cancer Strategic Insights

Strategic insights for North America Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-colorectal-cancer-market-strategic-framework.webp
Get more information on this report

North America Colorectal Cancer Report Scope

Report Attribute Details
Market size in 2022 US$ 8,559.27 Million
Market Size by 2028 US$ 11,198.11 Million
Global CAGR (2022 - 2028) 3.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By モダリティ
  • 診断タイプ
  • 治療タイプ
  • 画像タイプ
By エンドユーザー
  • 病院
  • 診断および研究機関
Regions and Countries Covered 北米
  • 米国
  • カナダ
  • メキシコ
Market leaders and key company profiles
  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Get more information on this report

    North America Colorectal Cancer Regional Insights

    The regional scope of North America Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-colorectal-cancer-market-geography.webp
    Get more information on this report

    The List of Companies - North America Colorectal Cancer Market

    1. Abbott
    2. Amgen Inc.
    3. Bruker Corporation
    4. Clinical Genomics Technologies Pty Ltd.
    5. Epigenomics AG
    6. F. Hoffmann-La Roche AG
    7. Quest Diagnostics  
    8. VolitionRx Limited
    Frequently Asked Questions
    How big is the North America Colorectal Cancer Market?

    The North America Colorectal Cancer Market is valued at US$ 8,559.27 Million in 2022, it is projected to reach US$ 11,198.11 Million by 2028.

    What is the CAGR for North America Colorectal Cancer Market by (2022 - 2028)?

    As per our report North America Colorectal Cancer Market, the market size is valued at US$ 8,559.27 Million in 2022, projecting it to reach US$ 11,198.11 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.

    What segments are covered in this report?

    The North America Colorectal Cancer Market report typically cover these key segments-

  • モダリティ (診断タイプ, 治療タイプ, 画像タイプ)
  • エンドユーザー (病院, 診断および研究機関)
  • What is the historic period, base year, and forecast period taken for North America Colorectal Cancer Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Cancer Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Colorectal Cancer Market?

    The North America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Who should buy this report?

    The North America Colorectal Cancer Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.